logo

Health News

Share
ecigeratte-oct18.jpgAt a time, when e-cigarettes have been getting a lot of bad press, a new study has found a positive association between the number of people using e-cigarettes and the success rate of giving up smoking. The study led by Dr. Emma Beard, UCL Division of Psychology and Language Sciences, showed that...
Read More

CannTrust Holdings Inc. said that the New York Stock Exchange or NYSE notified the embattled Canada-based cannabis company that it is no longer in compliance with the NYSE's continued listing standard rules as the company's per share trading price has fallen below the stock exchange's share price rule. The...
Read More
elmiron-oct14.jpg

Interstitial Cystitis Drug Linked To Retinal Damage: Study



Elmiron, the only FDA-approved oral drug to treat interstitial cystitis, also known as bladder pain syndrome, has been found to be associated with a vision-threatening eye condition, according to a new study.
Read More
pigs-april18.jpg

No Piggy Tale: Some Brain Functions Restored Even Hours After Death



The conventional wisdom is that if the brain cells of humans and other mammals are deprived of oxygen for 4-5 min, they begin to die, and that the loss of brain functions after death is irreversible. But the findings of a study conducted by Yale University researchers challenge these long-held assumptions.
Read More
bornbaby-sept30.jpgA recent study, done by researchers from the Wellcome Sanger Institute, UCL, the University of Birmingham and their collaborators, found that there is a difference in the gut bacteria of babies delivered vaginally and those born via caesarean.
Read More
Follow RTT


FDA Calendar
Event DateSymbolDrug NameEvent Name
03/08/20HZNPTeprotumumab (BLA)FDA decision on Teprotumumab for the treatment of active thyroid eye disease
02/27/20BGNEZanubrutinib (NDA)FDA decision on Zanubrutinib for the treatment of patients with mantle cell lymphoma
02/26/20ESPRBempedoic Acid / Ezetimibe Combination Tablet (NDA)FDA decision on bempedoic acid / ezetimibe combination tablet for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C)
02/26/20GBTVoxelotor (NDA)FDA decision on Voxelotor for the treatment of sickle cell disease
02/21/20ALDREptinezumab (BLA)FDA decision on Eptinezumab for migraine prevention
02/21/20ESPRBempedoic Acid (NDA)FDA decision on Bempedoic Acid for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C)
View All




>